LASIK Manufacturers Rally For Eye Institute; Youthful Market In View For Visx
This article was originally published in The Gray Sheet
Executive Summary
The National Alliance for Eye & Vision Research is proposing that the budget for the National Eye Institute increase roughly 12.3% to $711 mil. in fiscal 2004
You may also be interested in...
Refractec Focuses On CK Astigmatism, Post-LASIK Treatment Indications
Refractec expects approval of a presbyopia indication for its CK Blended Vision radio wave procedure in early 2004, the company announced Sept. 30
Refractec Focuses On CK Astigmatism, Post-LASIK Treatment Indications
Refractec expects approval of a presbyopia indication for its CK Blended Vision radio wave procedure in early 2004, the company announced Sept. 30
Boston Scientific Taxus PMA, Visx CustomVue Approval Spark Q2 Index Gains
Anticipation of Boston Scientific's Taxus drug-eluting stent premarket approval submission to FDA helped lift the company's stock price by 50% in the second quarter, signaling investor confidence that the device successfully meets primary clinical endpoints